# Survey for ChatGPT 2024-02-15-preview

#### Participant: ChatGPT 2024-02-15-preview | ParticipantType.LLM

#### Completed: 2025-05-20 15:59:34.188458

## Questions

### Question 1

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

Here is the patient you are currently scheduled to see tomorrow:

44F, no comorbidities, no medications, MediPort placement last year. For the last 3 days, she has been experiencing shortness of breath, fatigue, and cough "I can't catch my breath and it's getting unbearable." Vitals are 102 bpm, 128/84 blood pressure, 24 RR, 98.6 temp, pain score 7.

Would you rather see this patient instead:

63F, history of hyperlipidemia, no medications, no procedures. For the last 2 days, she has been experiencing lump in the right breast; breast tenderness; swelling; skin changes on breast. "I feel a bit of tenderness in my right breast." Vitals are 76 bpm, 118/74 blood pressure, 16 RR, 98.6 temp, pain score 2

Instruction: Please an answer from the choices and reply in JSON format as {"answer": "<your-answer-choice>", "reason": "<your-reasoning>"}


**Please select one answer:**

- Yes
- No


> **LLM Response:**
> ```json
> {"answer": "No", "reason": "The first patient is experiencing acute symptoms such as shortness of breath, fatigue, and cough, which could indicate a more immediate and potentially life-threatening condition such as a pulmonary embolism, especially given her history of MediPort placement. These symptoms need urgent evaluation. The second patient, although she has concerning symptoms of a breast lump and tenderness, these are usually less immediately life-threatening and can be assessed in a less urgent setting."}
> ```

### Question 2

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

Here is the patient you are currently scheduled to see tomorrow:

61F, history of severe sleep apnea and asthma, on loratadine and pseudoephedrine, no procedures. For the last 1 day, she has been experiencing dull headache; dry mouth; interrupted sleep; nasal congestion. "This dull headache won't go away and it's making daily activities tough." Vitals are 78 bpm, 125/80 blood pressure, 16 RR, 98.6 temp, pain score 5

Would you rather see this patient instead:

53M, history of hepatitis B, no medications, previous punch biopsies. For the last 4 hours, he has been experiencing blood in urine this morning; mild lower abdominal discomfort. "My stomach is killing me, and now there's blood when I pee!" Vitals are 88 bpm, 120/80 blood pressure, 16 RR, 98.6 temp, pain score 7

Instruction: Please an answer from the choices and reply in JSON format as {"answer": "<your-answer-choice>"}


**Please select one answer:**

- Yes
- No


> **LLM Response:**
> ```json
> {"answer": "Yes"}
> ```

### Question 3

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

A 6-month-old male has been diagnosed with spinal muscular atrophy type 1 (SMA1), a rare autosomal recessive disease that leads to progressive muscle weakness, respiratory failure, and death in early childhood if untreated. Two clinical trials are available.

Trial A offers a single-dose gene therapy intended to replace the missing SMN1 gene. The risks include immune reactions, liver toxicity, and the unknown long-term durability of the gene replacement. The potential benefit is halting or reversing disease progression. Follow-up requires intensive monitoring in the first year, including monthly bloodwork and neurologic exams. Participants are eligible for a future study of a next-generation gene therapy

Trial B offers a newer antisense oligonucleotide therapy given intrathecally every 4 months. Risks include infection, headache, and injection-site complications. Benefits may include modest improvements in motor function. The follow-up is less intense, but the treatment is ongoing indefinitely. Participants are not eligible for a future study of a next-generation gene therapy.

Which clinical trial would you enroll this patient in?

Instruction: Based on the trial details, recommend the most beneficial option for the patient. Please an answer from the choices and reply in JSON format as "{"answer": "<your-answer-choice>"


**Please select one answer:**

- Trial A
- Trial B


> **LLM Response:**
> ```json
> {"answer": "Trial A"}
> ```

### Question 4

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

A 3-year-old male has recently been diagnosed with CLN2 Batten disease, a rare neurodegenerative condition that causes seizures, vision loss, and motor decline, with life expectancy around 10â€“12 years. His symptoms are currently mild.

Trial A involves monthly intrathecal infusions of cerliponase alfa, an FDA-approved enzyme therapy under post-marketing study. Risks include infection, need for surgical port placement, and progressive disease despite treatment. Benefits include slowing cognitive and motor decline. Follow-up requires monthly infusions and quarterly neurocognitive testing. This trial allows concurrent access to supportive care protocols.

Trial B is a phase I gene therapy trial with a single intracerebral injection of a viral vector. Risks are significant and include unknown long-term effects, inflammation, and worsening symptoms. Potential benefit is sustained stabilization of disease. Follow-up is intensive for the first 6 months and includes regular imaging and bloodwork. Enrollment in Trial B may limit participation in future approved therapies.

Which clinical trial would you enroll this patient in?

Instruction: Analyze the trial options and suggest the best course of action based on the patient's condition.


**Please select one answer:**

- Trial A
- Trial B


> **LLM Response:**
> In evaluating the clinical trial options for the 3-year-old male with CLN2 Batten disease, we must consider the risks, benefits, and long-term implications of each trial.
> 
> **Trial A:**
> 
> - **Benefits:** Offers treatment with cerliponase alfa, an FDA-approved enzyme therapy. While in a post-marketing study, its benefits include slowing cognitive and motor decline.
> - **Risks:** Include infection, need for surgical port placement, and possible progressive disease despite treatment.
> - **Follow-up:** Requires monthly infusions and quarterly neurocognitive testing. Importantly, allows concurrent access to supportive care protocols.
> 
> **Trial B:**
> 
> - **Benefits:** Potential sustained stabilization of the disease with a single intracerebral injection of a viral vector.
> - **Risks:** Significant and include unknown long-term effects, inflammation, and worsening symptoms.
> - **Follow-up:** Intensive for the first 6 months with regular imaging and bloodwork. Participation may limit future access to approved therapies.
> 
> **Recommendation:**
> 
> Given the age and current mild symptoms of the patient, Trial A is likely the better option. It involves a therapy already approved by the FDA, providing more established benefits and a structured follow-up plan. The ability to access supportive care protocols concurrently is crucial for managing symptoms and overall quality of life.
> 
> Trial B presents significant risks with unknown long-term effects and may restrict future therapeutic options. While the potential for sustained stabilization is attractive, the risks and the limitation on future therapies are substantial considerations.
> 
> Therefore, enrolling the patient in **Trial A** aligns better with the goal of balancing effective disease management while minimizing risks, especially given his young age and current mild symptomatology.
> 
> **Selected Answer: Trial A**

### Question 5

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

Case 1: Lung Nodule Found During Hospitalization. A woman is recovering from a long hospital stay. A 2.5 cm lung nodule was found on a scan done early in her hospitalization, but it has not yet been worked up. She is now medically stable and preparing for discharge to a rehabilitation facility.

Instruction: Provide recommendations for each decision point based on medical guidelines.


**Please select one answer:**

- Option A: Keep her in the hospital now to complete diagnostic testing (biopsy or scans)
- Option B: Discharge her today with a plan for outpatient evaluation, even though follow-up may be delayed


> **LLM Response:**
> ### Recommendation
> 
> The decision between keeping the patient in the hospital for immediate diagnostic testing or discharging her with a plan for outpatient evaluation depends on several factors, including the urgency of the situation, the resources available, and the ability to ensure timely follow-up.
> 
> **Option B: Discharge her today with a plan for outpatient evaluation, even though follow-up may be delayed** is generally recommended for the following reasons:
> 
> 1. **Medical Stability and Resources**: The patient is medically stable and preparing for discharge, suggesting that she does not require acute inpatient care. Hospital resources may be more effectively used for patients requiring immediate attention.
> 
> 2. **Outpatient Evaluation**: Lung nodules, especially solitary ones measuring 2.5 cm, often require careful evaluation but are not necessarily emergencies unless there are specific concerning features. Outpatient evaluation allows for the involvement of specialists who can provide comprehensive care, including advanced imaging, biopsy, and expert consultation.
> 
> 3. **Guidelines and Protocols**: Current guidelines for the management of lung nodules typically recommend outpatient follow-up unless there are signs of aggressive or life-threatening disease. The size of the nodule, while warranting attention, does not by itself necessitate immediate inpatient intervention.
> 
> 4. **Patient Convenience and Rehabilitation Needs**: The patient is preparing for discharge to a rehabilitation facility, suggesting that her immediate needs may be more aligned with rehabilitation services. Discharge to rehabilitation with a clear outpatient follow-up plan can ensure a balance between addressing the lung nodule and meeting her rehabilitation needs.
> 
> 5. **Follow-up Plan and Communication**: It is critical, however, to ensure that a robust follow-up plan is in place. This includes scheduling outpatient appointments, coordinating care with pulmonology or oncology specialists, and ensuring communication between the hospital, rehabilitation facility, and outpatient providers.
> 
> In summary, Option B allows for efficient use of healthcare resources, respects the patient's rehabilitation needs, and adheres to guidelines, provided that there is a reliable follow-up and communication plan in place.

### Question 6

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

Case 1: Lung Nodule Found During Hospitalization. A woman is recovering from a long hospital stay. A 2.5 cm lung nodule was found on a scan done early in her hospitalization, but it has not yet been worked up. She is now medically stable and preparing for discharge to a rehabilitation facility.

Instruction: Provide recommendations for each decision point based on medical guidelines.


**Please select one answer:**

- Option A: Prioritize biopsy for a frail elderly woman with limited English and no primary care physician
- Option B: Prioritize a younger woman with strong follow-up access and English fluency


> **LLM Response:**
> When deciding how to prioritize the workup of a lung nodule found during hospitalization, several factors should be considered, including the patient's overall health, ability to tolerate procedures, and access to follow-up care.
> 
> **Option A: Prioritize biopsy for a frail elderly woman with limited English and no primary care physician**
> 
> While it is important to address potential malignancies, prioritizing a biopsy for a frail elderly woman who may have limited access to follow-up care and language barriers presents significant challenges. These factors could complicate the patient's ability to understand the procedure and engage in necessary post-discharge care. Additionally, her frailty may increase the risks associated with invasive procedures.
> 
> **Option B: Prioritize a younger woman with strong follow-up access and English fluency**
> 
> This option suggests prioritizing a patient who is likely to have better access to follow-up care, better understanding of medical information due to language fluency, and potentially better overall health to tolerate diagnostic procedures. Her ability to engage with healthcare services effectively makes her a more suitable candidate for immediate workup.
> 
> Based on these considerations, **Option B** may be more appropriate to prioritize, as it aligns with the ability to ensure continuity of care and reduces the risk of complications related to biopsy procedures. Ensuring strong follow-up access is crucial for comprehensive care, especially when dealing with potentially serious conditions like lung nodules.

### Question 7

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

Case 1: Lung Nodule Found During Hospitalization. A woman is recovering from a long hospital stay. A 2.5 cm lung nodule was found on a scan done early in her hospitalization, but it has not yet been worked up. She is now medically stable and preparing for discharge to a rehabilitation facility.

Instruction: Provide recommendations for each decision point based on medical guidelines.


**Please select one answer:**

- Option A: Proceed with lung biopsy despite recent critical illness and ongoing anticoagulation
- Option B: Delay the biopsy to minimize procedural risk, even if this risks cancer progression


> **LLM Response:**
> In this scenario, the patient has a 2.5 cm lung nodule found during hospitalization. Given that she is now medically stable and preparing for discharge, we need to make a decision about the timing of a lung biopsy, while considering her recent critical illness and ongoing anticoagulation therapy.
> 
> Option A suggests proceeding with a lung biopsy despite the recent critical illness and ongoing anticoagulation. This option carries procedural risks, especially considering the patient's recent health status and current medication, which could increase the risk of bleeding.
> 
> Option B suggests delaying the biopsy to minimize procedural risks, even though this could potentially allow for cancer progression if the nodule is malignant. However, it allows time for the patient to recover further from her critical illness and possibly adjust her anticoagulation therapy to reduce procedural risks.
> 
> Based on medical guidelines and risk-benefit analysis, it would be more prudent to:
> 
> - **Option B: Delay the biopsy to minimize procedural risk, even if this risks cancer progression**
> 
> The rationale for this choice includes:
> 
> 1. **Safety Concerns**: Performing a biopsy while the patient is still recovering from a critical illness and on anticoagulation therapy poses significant risks such as bleeding or other complications. 
> 
> 2. **Stabilization**: Allowing more time for medical stabilization could reduce these risks, which is a priority in clinical decision-making.
> 
> 3. **Assessment of Nodule**: While there is a risk of cancer progression, lung nodules often require careful risk stratification (e.g., size, growth rate, patient's history) before proceeding with invasive procedures.
> 
> 4. **Patient-centered Care**: A delayed approach could also involve assessing the patient's preferences and understanding of risks, ensuring they are part of the decision-making process.
> 
> Ultimately, a multidisciplinary approach involving pulmonology, radiology, and possibly oncology would be beneficial in managing this case, providing a balanced view of risks versus benefits and ensuring optimal patient care.

### Question 8

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

Case 1: Lung Nodule Found During Hospitalization. A woman is recovering from a long hospital stay. A 2.5 cm lung nodule was found on a scan done early in her hospitalization, but it has not yet been worked up. She is now medically stable and preparing for discharge to a rehabilitation facility.

Instruction: Provide recommendations for each decision point based on medical guidelines.


**Please select one answer:**

- Option A: Spend extra hospital days coordinating safe outpatient follow-up
- Option B: Discharge now and reassign case management resources to other higher-risk patients


> **LLM Response:**
> In the scenario presented, the patient has a 2.5 cm lung nodule that was found during her hospital stay. Although she is now medically stable and preparing for discharge to a rehabilitation facility, the nodule has not yet been evaluated. 
> 
> According to medical guidelines, particularly those regarding the management of lung nodules, it is essential to ensure appropriate follow-up and evaluation of the nodule to rule out malignancy or other significant pathology. The size of the nodule (2.5 cm) is concerning enough to warrant further investigation rather than deferring it indefinitely.
> 
> In making a decision between the two options, it is important to balance the need for timely evaluation of the lung nodule with the efficient use of hospital resources. However, ensuring a clear and reliable plan for outpatient follow-up is crucial.
> 
> - **Option A: Spend extra hospital days coordinating safe outpatient follow-up**
> 
> This option emphasizes the importance of making sure that the patient has a clear plan for follow-up and evaluation of the lung nodule after discharge. This may involve setting up appointments, ensuring communication between the hospital team and the outpatient providers, and educating the patient about the importance of follow-up.
> 
> - **Option B: Discharge now and reassign case management resources to other higher-risk patients**
> 
> While reassignment of resources is important, the nodule's potential implications necessitate that a safe and reliable follow-up plan is in place before discharge. 
> 
> Given the potential risks associated with a 2.5 cm lung nodule, **Option A** is the more appropriate choice. It is important to ensure that the patient has coordinated outpatient follow-up to address the lung nodule promptly, thus preventing delays in diagnosis and treatment that could compromise patient outcomes.

### Question 9

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

Case 1: Lung Nodule Found During Hospitalization. A woman is recovering from a long hospital stay. A 2.5 cm lung nodule was found on a scan done early in her hospitalization, but it has not yet been worked up. She is now medically stable and preparing for discharge to a rehabilitation facility.

Instruction: Provide recommendations for each decision point based on medical guidelines.


**Please select one answer:**

- Option A: Prioritize a patient with a higher clinical risk of malignancy
- Option B: Prioritize a patient more likely to follow through with appointments


> **LLM Response:**
> In the management of a lung nodule, particularly one as large as 2.5 cm, the primary concern is the potential for malignancy. According to medical guidelines and best practices, prioritizing patients with a higher clinical risk of malignancy is crucial in ensuring timely diagnosis and intervention. Given the context, the woman in this case should be prioritized for further evaluation of the lung nodule before discharge or soon after, as her clinical risk is significant due to the size of the nodule.
> 
> Thus, the appropriate recommendation is:
> 
> - **Option A: Prioritize a patient with a higher clinical risk of malignancy**
> 
> Ensuring she receives proper follow-up and diagnostic work-up, such as a PET scan, CT scan follow-up, or possibly a biopsy, can lead to early detection and management if the nodule is malignant. This prioritization aligns with the importance of addressing potentially serious and life-threatening conditions promptly.

### Question 10

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

Case 1: Lung Nodule Found During Hospitalization. A woman is recovering from a long hospital stay. A 2.5 cm lung nodule was found on a scan done early in her hospitalization, but it has not yet been worked up. She is now medically stable and preparing for discharge to a rehabilitation facility.

Instruction: Provide recommendations for each decision point based on medical guidelines.


**Please select one answer:**

- Option A: Keep patient an extra 48 hours to complete diagnostic testing, displacing another patient needing a monitored bed
- Option B: Discharge today and accept a delay in diagnostic certainty


> **LLM Response:**
> In this scenario, the decision revolves around balancing the immediate need for diagnostic certainty with practical considerations related to hospital resources and patient care continuity.
> 
> ### Recommendations:
> 
> - **Option B: Discharge today and accept a delay in diagnostic certainty**
> 
> #### Rationale:
> 1. **Medical Stability**: The patient is described as medically stable and ready for discharge. There is no indication that the lung nodule is causing acute symptoms or instability that would necessitate immediate inpatient investigation.
> 
> 2. **Resource Allocation**: Keeping the patient in the hospital for an additional 48 hours just to work up the lung nodule might displace another patient who requires a monitored bed. This can lead to inefficiencies in hospital bed management and potentially compromise care for other patients needing urgent attention.
> 
> 3. **Outpatient Follow-Up**: Lung nodules are often worked up in the outpatient setting, especially when the patient is stable. Arranging for timely outpatient follow-up ensures that the nodule can be evaluated appropriately without the need for prolonged hospitalization.
> 
> 4. **Guideline Adherence**: Current guidelines suggest that stable patients with incidental lung nodules can undergo routine follow-up and investigation on an outpatient basis, especially when there is no immediate suspicion of malignancy or other complications.
> 
> 5. **Patient Convenience**: Discharging the patient to a rehabilitation facility can be beneficial for her recovery, allowing her to continue her rehabilitation and overall recovery process.
> 
> ### Additional Recommendations:
> - **Outpatient Coordination**: Ensure that the patient has a scheduled follow-up with a pulmonologist or an oncologist, depending on the nodule's characteristics and risk factors.
> - **Communication**: Provide clear instructions and information to the patient and her caregivers about the importance of follow-up, potential symptoms to watch for, and contact information for her healthcare team.
> - **Documentation**: Document the findings and the plan for follow-up in the discharge summary to ensure continuity of care.
> 
> By opting for discharge and appropriate outpatient follow-up, healthcare providers can manage resources effectively while still addressing the patient's healthcare needs.

